CoChat

Alzheimer disease

Open access
Knopman, David S., Amieva, Helene, Petersen, Ronald C., Chételat, Gäel, Holtzman, David M., Hyman, Bradley T., Nixon, Ralph A., Jones, David T. · 2021 · Nature Reviews Disease Primers

The DOI matches its Crossref record; 289 of the 289 references it cites were found in a registry or an index.

Abstract

Alzheimer disease (AD) is biologically defined by the presence of β-amyloid-containing plaques and tau-containing neurofibrillary tangles. AD is a genetic and sporadic neurodegenerative disease that causes an amnestic cognitive impairment in its prototypical presentation and non-amnestic cognitive impairment in its less common variants. AD is a common cause of cognitive impairment acquired in midlife and late-life but its clinical impact is modified by other neurodegenerative and cerebrovascular conditions. This Primer conceives of AD biology as the brain disorder that results from a complex interplay of loss of synaptic homeostasis and dysfunction in the highly interrelated endosomal/lysosomal clearance pathways in which the precursors, aggregated species and post-translationally modified products of Aβ and tau play important roles. Therapeutic endeavours are still struggling to find targets within this framework that substantially change the clinical course in persons with AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41572-021-00269-y

Cites

289 of 289 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

8 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 289 references

Research works printed but not linked: 3

  1. Tom, S. E. et al. Trends in incident dementia and early life socieoeconomic status by birth cohort in the adult changes in thought study. JAMA Open 3, e2011094 (2020).
  2. El Far, O. & Seagar, M. A role for V-ATPase subunits in synaptic vesicle fusion? J. Neurochem. 117, 603–612 (2011).
  3. Shugart, J. https://www.alzforum.org/news/conference-coverage/banish-av-ban2401-antibody-makes-its-move-phase-3-program (2020).

Cited by

See all 2,606

Metadata

Authors
Knopman, D. S., Amieva, H., Petersen, R. C., Chételat, G., Holtzman, D. M., Hyman, B. T., Nixon, R. A., & Jones, D. T.
Affiliations
  • Mayo Clinic (US)
  • Washington University in St. Louis (US)
  • Massachusetts General Hospital (US)
  • NYU Langone Health (US)
Corresponding author
Knopman, David S.
Venue
Nature Reviews Disease Primers
Published
2021-05-13
Volume
7
Issue
1
Pages
33-33
ISSN
2056-676X (ISSN-L)
OpenAlex
W4211036635
Cited by
2,606
References
289
Citations by year
2026: 511 · 2025: 681 · 2024: 629 · 2023: 454 · 2022: 295 · 2021: 32
FWCI
47.26
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Reviews Disease Primers (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • HAL (submittedVersion)
  • Oskar-Bordeaux (Universite de Bordeaux) (submittedVersion)
Funders
National Institute on Aging (U01AG006786, P01AG017617, R01AG062376, P30AG062677, P30AG062421)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Alzheimer's disease, amyloid plaques, neurofibrillary tangles, synaptic homeostasis, amyloid fibril formation, post-translational modification, risk factors, diagnosis, disease management, quality of life, neurodegeneration, cerebrovascular disease
MeSH terms
Alzheimer Disease, Humans, Amyloid beta-Peptides, Neurofibrillary Tangles, Neurodegenerative Diseases, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Alzheimer disease. https://app.cochat.ai/papers/10.1038/s41572-021-00269-y
The paper
Knopman, D. S., Amieva, H., Petersen, R. C., Chételat, G., Holtzman, D. M., Hyman, B. T., Nixon, R. A., & Jones, D. T. (2021). Alzheimer disease. Nature Reviews Disease Primers. https://doi.org/10.1038/s41572-021-00269-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.